2BB score and signals
Neurogene Inc.’s current 2BB score is 52 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 70 | High |
| Momentum | 58 | Stable |
| Financial strength | 3 | Very Weak |
| Quality | 98 | Very Strong |
| Risk | 55 | Moderate |
Company facts
| CEO | Jonathan Drachman M.D. |
| Founded | 2018 |
| Employees | 131 |
| 52-week range | $15.93 – $43.66 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-03-22 | — | -1.3441 | — | $0.00 |
| 2026-11-11 | — | -1.3589 | — | $0.00 |
| 2026-08-07 | — | -1.4518 | — | $0.00 |
| 2026-05-12 | -1.39 | -1.3222 | $0.00 | $0.00 |
Related companies
